Ayurveda wellness brand Kapiva has raised $60 million in its Series D round led by 360 ONE Asset and Vertex Growth, with continued backing from Vertex Ventures Southeast Asia and India, and 3one4 Capital. Early investor Fireside Ventures fully exited in this round, which also saw a $28 million primary infusion.
Founded in 2015 by Ameve Sharma and Shrey Badhani, Kapiva has built a fast-growing portfolio of ayurvedic nutrition products across categories including diabetes, hypertension, liver health, hormonal balance, energy, and sports nutrition. Its products are sold online, via e-commerce platforms, and through a network of 40,000 offline retail stores nationwide.
The company plans to deploy the new funds into R&D, manufacturing expansion, brand building, and scaling its health-tech platform. A key focus will be chronic condition management and personalised care, reflecting the growing demand for Ayurveda-driven preventive healthcare solutions.
Kapiva has shown strong financial momentum. It currently operates at an annual revenue run rate of Rs 550 crore, up from Rs 350 crore in FY25, and has grown over 80% year-on-year for the past three years. While still marginally EBITDA negative, the firm expects to turn profitable in the coming quarter.
In FY24, Kapiva doubled its revenue to Rs 228 crore while cutting losses to Rs 56 crore. With nearly $90 million raised to date, the company is now positioning itself as one of India’s most scaled Ayurveda-first wellness brands, competing with Innovacare, Gynoveda, and Wellbeing Nutrition.
As India’s preventive healthcare market matures, Kapiva’s next phase will test whether Ayurveda can scale into a tech-enabled, mass wellness ecosystem while maintaining its roots in natural care.
Stay curious. Stay ambitious. Stay connected with StartupStoryindia.
